Skip to main content

Share story

Infrastructure AI

Cloudflare makes Python Workers generally available

Cloudflare makes Python Workers generally available Image: Primary
Cloudflare made Python a fully supported language on its Workers platform, moving a two-year-old capability into general availability. Developers can now connect Python applications directly to Workers AI, storage, databases, queues and workflows, while running frameworks including FastAPI, Django and Flask. The runtime automatically converts objects across the Python-JavaScript boundary and translates Python socket operations into Workers networking calls, enabling PostgreSQL and MySQL drivers through Hyperdrive. It uses a WebAssembly-compiled Python interpreter, so packages with native extensions still require compatible PyEmscripten builds, an ecosystem that remains under development.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Posts tagged "Developers" and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...